SE7705295L - Forfarande for framstellning av 2- och 3-substituerade enkefaliner - Google Patents

Forfarande for framstellning av 2- och 3-substituerade enkefaliner

Info

Publication number
SE7705295L
SE7705295L SE7705295A SE7705295A SE7705295L SE 7705295 L SE7705295 L SE 7705295L SE 7705295 A SE7705295 A SE 7705295A SE 7705295 A SE7705295 A SE 7705295A SE 7705295 L SE7705295 L SE 7705295L
Authority
SE
Sweden
Prior art keywords
widow
falls
substituted
procedure
preparation
Prior art date
Application number
SE7705295A
Other languages
English (en)
Swedish (sv)
Inventor
Jr D A Jones
R H Mazur
J A Reuter
R A Mikulec
J M Schlatter
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of SE7705295L publication Critical patent/SE7705295L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7705295A 1976-05-07 1977-05-06 Forfarande for framstellning av 2- och 3-substituerade enkefaliner SE7705295L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/684,321 US4028319A (en) 1976-05-07 1976-05-07 2 and 3-substituted enkephalins

Publications (1)

Publication Number Publication Date
SE7705295L true SE7705295L (sv) 1977-11-08

Family

ID=24747593

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7705295A SE7705295L (sv) 1976-05-07 1977-05-06 Forfarande for framstellning av 2- och 3-substituerade enkefaliner

Country Status (11)

Country Link
US (1) US4028319A (cs)
JP (1) JPS52139040A (cs)
AU (1) AU508251B2 (cs)
BE (1) BE854397A (cs)
DE (1) DE2720152A1 (cs)
ES (1) ES458537A1 (cs)
FR (1) FR2397394A1 (cs)
GB (1) GB1526617A (cs)
NZ (1) NZ184020A (cs)
SE (1) SE7705295L (cs)
ZA (1) ZA772758B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371463A (en) * 1977-02-17 1983-02-01 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-resistant opiate pentapeptides
US4075190A (en) * 1977-03-14 1978-02-21 American Home Products Corporation Pentapeptide with morphine-like activity
US4198398A (en) * 1977-07-12 1980-04-15 Derek Hudson Enkephalin analogues
GB1604850A (en) * 1977-11-24 1981-12-16 Wellcome Found Biologically active peptides
US4264491A (en) * 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
US4148786A (en) * 1978-06-26 1979-04-10 American Home Products Corporation Analgesic polypeptide
US4199499A (en) * 1978-08-24 1980-04-22 Eli Lilly And Company Pharmacologically active peptides
US4304715A (en) * 1979-06-08 1981-12-08 Derek Hudson Enkephalin analogues
EP0053029A1 (en) * 1980-11-24 1982-06-02 Peninsula Laboratories Incorporated Non enkephalin-like peptides, their production, compositions containing them, and their medical and veterinary use
ES2146651T3 (es) * 1994-05-12 2000-08-16 Balazs Sarkadi Compuestos para anular resistencias a medicamentos.

Also Published As

Publication number Publication date
NZ184020A (en) 1979-12-11
AU508251B2 (en) 1980-03-13
BE854397A (fr) 1977-11-09
AU2489777A (en) 1978-11-09
DE2720152A1 (de) 1977-11-17
ES458537A1 (es) 1978-04-01
FR2397394A1 (fr) 1979-02-09
GB1526617A (en) 1978-09-27
JPS52139040A (en) 1977-11-19
ZA772758B (en) 1978-06-28
US4028319A (en) 1977-06-07
FR2397394B1 (cs) 1980-04-25

Similar Documents

Publication Publication Date Title
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
NO151269C (no) Fremgangsmaate for fremstilling av fiskemel
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
NO814065L (no) Fremgansmaate for fremstilling av imidazolylfenylamidiner
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE427838B (sv) Forfarande for framstellning av aromatiska uretaner
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE7705295L (sv) Forfarande for framstellning av 2- och 3-substituerade enkefaliner
NO150888C (no) Fremgangsmaate for fremstilling av et encelle-protein
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
SE441359B (sv) Forfarande for framstellning av nya klavulansyratioetrar
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO811628L (no) Fremgangsmaate for fremstilling av karbapenam- og karbapen-2-em-derivater.
SE7706236L (sv) Forfarande for framstellning av overdrag
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE428016B (sv) Forfarande for framstellning av 6a,10a-cis - hexahydrodibensopyranonderivat
SE7714872L (sv) Forfarande for framstellniong av halogenacylamider
SE7701667L (sv) Forfarande for framstellning av cefalosporin-antibiotika
SE416545B (sv) Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat